Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q2 2026 · 10-Q
Revenue$395.99K$395.99K−21.4% vs Q2 2025 Net Income-$1.88M-$1.88MN/M vs Q2 2025 EPS, diluted—
Gross Profit$235,536−22.2% Operating Income-$724,150N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Operating Cash Flowderived-$223,881N/M Margins · derivedGross margin59.5%−0.6 pt vs Q2 2025
Operating margin-182.9%+186.2 pt vs Q2 2025
Net margin-475.6%−101.0 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end